儿童2型喘患者有资格接受dupilumab:一个基于生物标志物的意大利分析
Giorgio Piacentini1, Alessandro Fiocchi2, Gianluigi Marseglia3
1AOUI Verona, University of Verona, Verona, Italy.
The World Allergy Organization journal
|August 19, 2024
概括
这项研究发现,在意大利,有85.8%的6至11岁儿童患有严重失控的喘,有资格接受dupilumab治疗. 生物标志物测试,包括乙氨基 (EOS),免疫球蛋白-E (IgE) 和呼出的氧化 (FeNO) 分数,有助于识别合适的候选人.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型炎症是儿科喘的关键驱动因素,与乙氨基酸 (EOS) 激活,免疫球蛋白-E (IgE) 生产和呼出的氧化 (FeNO) 分数升高有关.
- 杜皮卢马布已获批准用于治疗2型非控制性严重喘的儿童.
研究的目的:
- 确定意大利6至11岁的患有严重失控喘的儿童有资格接受dupilumab的数量.
- 根据关键生物标志物水平来表征这种符合条件的儿科患者群体.
主要方法:
- 使用了两阶段的方法,首先估计了患有严重不受控制的喘的儿科总人数.
- 然后,根据生物标志物水平 (EOS,IgE,FeNO) 将人口分层,使用VOYAGE研究的数据来识别符合dupilumab资格的患者.
主要成果:
- 据估计,大约有1007名6至11岁的儿童患有严重的失控喘.
- 85.8% (864名患者) 被确定为符合杜皮卢马布治疗条件的患者.
- 大多数符合条件的患者 (73.5%) 至少有两种生物标志物升高,其中43.1%显示EOS,FeNO和IgE升高.
结论:
- 同时进行生物标志物测试 (EOS,FeNO,IgE) 对于评估儿童严重的2型喘患病率和表型至关重要.
- 这种方法有助于选择合适的疗法,如dupilumab,并监测治疗反应.
- 生物标志物分层使得儿童严重喘的个性化治疗策略成为可能.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
255
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
255
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
370
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
370
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
241
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
241
01:23Inhaled Medications
246
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
246